Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind Evaluation of Flumazenil and Gabapentin for the Treatment of Alcohol Withdrawal and Relapse Prevention

NCT00262639 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT00262639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00262639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind Evaluation of Flumazenil and Gabapentin for the Treatment of Alcohol Withdrawal and Relapse Prevention
Lead sponsor
Medical University of South Carolina
Phase
Phase 2/3
Overall status
Completed
Start date
December 31, 2005
Completion date
March 31, 2008
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence